Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Favipiravir treatment does not influence disease progression among adult patients hospitalized with moderate-to-severe COVID-19: a prospective, sequential cohort study from Hungary.
Szabo BG, Lenart KS, Petrik B, Gaspar Z, Kiss-Dala N, Szlavik J, Valyi-Nagy I, Lakatos B; Saint Ladislaus COVID-19 Collaborative. Szabo BG, et al. Among authors: kiss dala n. Geroscience. 2021 Oct;43(5):2205-2213. doi: 10.1007/s11357-021-00452-9. Epub 2021 Sep 3. Geroscience. 2021. PMID: 34476717 Free PMC article.
A COVID-19-association-dependent categorization of death causes in 100 autopsy cases.
Danics K, Pesti A, Törő K, Kiss-Dala N, Szlávik J, Lakatos B, Radnai A, Balázs T, Bacskai M, Dobi D, Várkonyi T, Glasz T, Lotz G, Kiss A, Schaff Z, Vályi-Nagy I. Danics K, et al. Among authors: kiss dala n. Geroscience. 2021 Oct;43(5):2265-2287. doi: 10.1007/s11357-021-00451-w. Epub 2021 Sep 11. Geroscience. 2021. PMID: 34510338 Free PMC article.
Laboratory parameters predicting mortality of adult in-patients with COVID-19 associated cytokine release syndrome treated with high-dose tocilizumab.
Lakatos B, Szabo BG, Bobek I, Gopcsa L, Beko G, Kiss-Dala N, Petrik B, Gaspar Z, Farkas BF, Sinko J, Remenyi P, Szlavik J, Valyi-Nagy I. Lakatos B, et al. Among authors: kiss dala n. Acta Microbiol Immunol Hung. 2021 Aug 6. doi: 10.1556/030.2021.01526. Online ahead of print. Acta Microbiol Immunol Hung. 2021. PMID: 34370690
Secondary infections and long-term outcomes among hospitalized elderly and non-elderly patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and treated with baricitinib: a comparative study from the national centre of Hungary.
Gáspár Z, Szabó BG, Andrikovics H, Ceglédi A, Rajmon M, Ábrahám A, Várnai Z, Kiss-Dala N, Szlávik J, Sinkó J, Vályi-Nagy I, Lakatos B. Gáspár Z, et al. Among authors: kiss dala n. Geroscience. 2024 Jun;46(3):2863-2877. doi: 10.1007/s11357-024-01099-y. Epub 2024 Feb 17. Geroscience. 2024. PMID: 38367195 Free PMC article.
Outcomes of high-risk adult outpatients treated with early remdesivir therapy during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron era: experiences from the national centre of Hungary.
Gáspár Z, Szabó BG, Ábrahám A, Várnai Z, Kiss-Dala N, Szlávik J, Sinkó J, Vályi-Nagy I, Lakatos B. Gáspár Z, et al. Among authors: kiss dala n. Naunyn Schmiedebergs Arch Pharmacol. 2023 Aug;396(8):1857-1862. doi: 10.1007/s00210-023-02456-y. Epub 2023 Mar 9. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36892627 Free PMC article.
Baricitinib vs tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: a prospective, investigational, real-world study.
Lakatos B, Szabó BG, Bobek I, Kiss-Dala N, Gáspár Z, Riczu A, Petrik B, Farkas BF, Sebestyén G, Gopcsa L, Bekő G, Sinkó J, Reményi P, Szlávik J, Mathiász D, Vályi-Nagy I. Lakatos B, et al. Among authors: kiss dala n. Int J Infect Dis. 2022 Dec;125:233-240. doi: 10.1016/j.ijid.2022.10.037. Epub 2022 Oct 31. Int J Infect Dis. 2022. PMID: 36328291 Free PMC article.